YR-001

N/A

Report date: 2026/05/22 20:01:29
NMEFirst In Class

Base Information

Drug NameYR-001
Drug Alias NameYR001YR-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated potassium channel subunit Kv1.3 blockers
TargetsVoltage-gated potassium channel subunit Kv1.3
Therapy Area/IndicationsPsoriasisAlopeciaDermatitis, Atopic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHangzhou Yirui Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHangzhou Yirui Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsPsoriasisAlopeciaDermatitis, Atopic +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A